Introduction: This study investigates how anxiety, depression, and sleep disorders impact heart rate variability (HRV) in the elderly, exploring the clinical implications of HRV changes.

Methods: We examined 355 patients (163 men, 192 women) at Xijing Hospital from July 2021 to December 2022 during health check-ups. Demographics were recorded, and emotional status was assessed using the Hamilton Anxiety Scale (HAMA) and the Hamilton Depression Scale (HAMD). The Pittsburgh Sleep Quality Scale (PSQI) evaluated sleep quality. Patients were categorized into groups A-G based on the presence of emotional states and sleep disorders. HRV indices-SDNN, SDANN, RMSSD, PNN50, LF/HF, LF, and HF-were analyzed using ANOVA and multivariate logistic regression.

Results: No statistically significant differences were observed in demographic, clinical, and lifestyle factors across the eight groups. Variables assessed included age, sex, body mass index (BMI), fasting blood glucose, glycated hemoglobin (HbA1c), blood lipids, blood pressure, heart rate, and histories of smoking and alcohol consumption. Additionally, the presence of hypertension, diabetes, coronary heart disease, marital status, income, and education level were evaluated, with all showing equivalence ( > 0.05). Significant differences in HRV indices were observed across groups, particularly in group G (patients with anxiety, depression and sleep disorders), which showed decreased HRV parameters except LF/HF, and group H (control group), which showed increased parameters, also except LF/HF ( < 0.01). Anxiety was an independent risk factor for reduced SDNN, SDANN, and LF ( ≤ 0.01), and increased LF/HF ratio ( < 0.01). Depression was linked to decreased SDNN, RMSSD, PNN50, and HF ( < 0.05). Sleep disorders independently predicted reduced PNN50 and SDANN ( < 0.01).

Conclusion: HRV indices of individuals with varying emotional states and sleep disorders exhibited varying degrees of decrease. Anxiety, depression, and sleep disorders presented a superimposed effect on HRV. SDNN, SDANN, RMSSD, PNN50, HF and LF of HRV are of great reference value in the diagnosis of emotional and sleep disorders. For elderly patients experiencing cognitive impairment, HRV is anticipated to serve as a convenient and effective tool for assessing mood and sleep disorders.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11798971PMC
http://dx.doi.org/10.3389/fpsyt.2025.1485183DOI Listing

Publication Analysis

Top Keywords

sleep disorders
36
anxiety depression
16
depression sleep
16
heart rate
12
rmssd pnn50
12
sleep
11
disorders
9
hrv
9
rate variability
8
disorders elderly
8

Similar Publications

Unraveling the Complexities of Sleep Disturbances: A Scientific Perspective.

J Contemp Dent Pract

December 2024

Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India; Multidisciplinary Department of Medical-Surgical and Dental Specialties, University of Campania "Luigi Vanvitelli", Naples, Italy, Phone: +39 3289129558, e-mail:

Uzunçıbuk H, Fiorillo L, Ronsivalle V, . Unraveling the Complexities of Sleep Disturbances: A Scientific Perspective. J Contemp Dent Pract 2024;25(12):1081-1083.

View Article and Find Full Text PDF

This article presents the clinical case of a 42-year-old woman with chronic pain in her left temporomandibular joint (TMJ) and limited mouth opening. The patient also reported anxiety and difficulty sleeping. Cone beam computed tomography revealed impacted maxillary third molars and hypertrophy of the nasal turbinates.

View Article and Find Full Text PDF

Background: Novel commercial brain-sense neurostimulators enable us to contextualize brain activity with symptom and medication states in real-life ambulatory settings in Parkinson's disease (PD). Although various candidate biomarkers have been proposed for adaptive deep brain stimulation (DBS), a comprehensive comparison of their ambulatory profiles is lacking.

Objectives: To systematically compare the ambulatory neurophysiological dynamics and clinical properties of three candidate biomarkers-low-frequency, beta (β), and finely tuned γ (FTG) activity.

View Article and Find Full Text PDF

Background: ADCY5-related dyskinesia is a rare disorder caused by mutations in the ADCY5 gene resulting in abnormal involuntary movements. Currently, there are no standardized guidelines to treat this condition.

Objective: The aim of this study was to evaluate the efficacy of theophylline administration in improving symptoms and quality of life in patients with ADCY5-related dyskinesia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!